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Abstract We recently described that there is a feedback
amplification of cytochrome c release from mitochondria by
caspases. Here we investigated how caspases impact on
mitochondria to induce cytochrome c release and found that
recombinant caspase-3 induced opening of permeability transi-
tion pore and reduction of membrane potential in vitro. These
events were inhibited by Bcl-xL, cyclosporin A and z-VAD.fmk.
Moreover, caspase-3 stimulated the rate of mitochondrial state
4 respiration, superoxide production and NAD(P)H oxidation
in a Bcl-xL- and cyclosporin A-inhibitable manner. These
results suggest that caspase-3 induces cytochrome c release by
inducing permeability transition pore opening which is asso-
ciated with changes in mitochondrial respiration and redox
potential. ß 2002 Published by Elsevier Science B.V. on be-
half of the Federation of European Biochemical Societies.
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1. Introduction
Mitochondria play a central role both in the production of
ATP and in regulating apoptosis, or programmed cell death
[1]. During the process of mitochondrial oxidative phosphor-
ylation, the electron transports along the respiratory chain
and generates a proton gradient across the mitochondrial in-
ner membrane to build proton motive force, including mito-
chondrial membrane potential (v8m) and vpH, to drive ATP
synthesis by F1F0-ATPase. The maintenance of the proton
motive force is critical for the normal function of mitochon-
dria. Perturbation of mitochondrial physiology could lead to
increased reactive oxygen production [2], damage to mito-
chondrial membranes and, consequently, apoptosis [1,3]. Mi-
tochondria could release apoptogenic factors such as cyto-
chrome c (cyt c) [4], Smac [5], apoptosis-inducing factor
(AIF) [6], caspases [7] and endonuclease G [8] to activate
the apoptotic cascade. Cyt c is a soluble protein located out-
side the inner mitochondrial membrane and functions as an
electron carrier of the mitochondrial respiration chain be-
tween complex III and complex IV. Once released, cyt c
acts as a co-factor in the presence of dATP to stimulate the
aggregation of Apaf-1, which can recruit and activate caspase-
9 and the downstream caspase cascade [4]. E¡ector caspases
then cleave cellular substrates at a speci¢c tetrapeptide se-
quence on the carboxyl side of aspartate residues and execute
programmed cell death [9]. The molecular mechanisms of the
regulation of the release of mitochondrial apoptogenic sub-
stances and its relationship with mitochondrial physiology
remain elusive.
Elucidating the mechanisms of cyt c release is crucial to the
understanding of how and why a cell makes a decision to
undergo apoptosis. The release of cyt c from mitochondria
could be the result of breakdown of the outer membrane of
mitochondria or opening of the permeability transition pore
(PTP) located in the contact site of the inner and outer mem-
brane of the mitochondria [10,11]. Bcl-2 and its related pro-
teins play an important role in regulating PTP, cyt c release
and caspase activation [12]. The molecular mechanisms of
how Bcl-2 and its related proteins regulate these events asso-
ciated with apoptosis remain a challenge ahead. There is evi-
dence that cyt c release could happen with or without PTP
opening [13,14]. Also there are reports showing that the re-
lease of cyt c could be downstream or upstream of caspase
activation depending on the systems employed [15]. Recently,
we observed that there is a feedback ampli¢cation of cyt c
release and PTP opening by caspases during genotoxic stress-
induced apoptosis [16]. We showed that, during the early stage
of apoptosis, there is a small amount of cyt c release, which is
su⁄cient to activate caspases. Once activated, caspases could
induce feedback ampli¢cation of cyt c release and mitochon-
drial dysfunction, though the mechanisms are not clear
[17,18]. Here, we show that recombinant caspase-3 directly
induced mitochondrial PTP opening, resulting in changes in
the mitochondrial redox status, mitochondrial dysfunction
and cyt c release.
2. Materials and methods
2.1. Materials
Sucrose, HEPES and IPTG were purchased from Life Technologies
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(Grand Island, NY, USA). Bovine serum albumin (BSA), ADP, car-
bonyl cyanide m-chlorophenylhydrazone (CCCP), cyclosporin A
(CsA), rhodamine 123 (Rh123), xanthine (X), xanthine oxidase
(XO) and H2DCFDA were obtained from Sigma (St. Louis, MO,
USA). Glutathione-Sepharose 4B was from Pharmacia (Uppsala,
Sweden). Ni-NTA agarose was from Qiagen (Hilden, Germany). z-
VAD.fmk was obtained from Biomol (Plymouth Meeting, PA, USA).
Cyt c antibody (clone 7H8.2C12) was from PharMingen (San Diego,
CA, USA). Other reagents were of analytical grade from commercial
sources in China.
2.2. Isolation of mitochondria and measurement of mitochondrial
permeability transition
Mitochondria were isolated from the liver of BALB/c mice. Brie£y,
the livers were taken after death and homogenized with a glass-Te£on
Potter homogenizer. Mitochondria were isolated in 250 mM sucrose,
2 mM HEPES, pH 7.4, 0.1 mM EDTA, 0.1% fatty acid-free BSA. All
steps were carried out on ice. Samples were centrifuged at 1000Ug for
10 min. The supernatant was transferred to another tube and centri-
fuged at 10 000Ug for 10 min. Mitochondria were washed twice, then
resuspended in the same medium and kept on ice for up to 4 h.
Protein content of mitochondria was determined by the microbiuret
method using BSA as standard. Mitochondrial swelling was moni-
tored by the decrease of 90‡ light scatter at 520 nm at 25‡C in medium
PT-1 containing 250 mM sucrose, 2 mM HEPES, pH 7.4, 0.5 mM
KH2PO4, 2 WM rotenone and 4.2 mM potassium succinate, using a
Jobin Yvon FluoroMax-2 spectro£uorimeter as described [13].
2.3. Expression and puri¢cation of recombinant proteins
Human Bcl-xL was expressed as glutathione S-transferase fusion
proteins in DH5K bacterial cells and puri¢ed on a glutathione-Sephar-
ose column [14]. His-tagged pET-CPP32 was expressed in BL21 bac-
terial cells and puri¢ed by Ni-NTA agarose (Qiagen) according to the
supplier’s protocol. Recombinant caspase-3 protein (1 U = 10 pmol/
min/mg) was evaluated by cleaving the DEVD-pNA before being used
for further experiments.
2.4. Measurement of oxygen consumption and respiratory control ratio
(RCR)
Using a Clark oxygen electrode, recombinant caspase-3-induced
changes in mitochondrial oxygen consumption rates were monitored
at 25‡C in medium PT-1 [19]. Statistical analysis was carried out with
the one-way ANOVA. Di¡erences were considered statistically signi¢-
cant at P6 0.05.
2.5. Determination of mitochondrial membrane potential
After addition of 30 nM Rh123 to a mitochondria suspension as
previously described [13], v8m was assessed at 25‡C in medium PT-1
by measuring the uptake of Rh123 using a spectro£uorimeter (Jobin
Yvon FluoroMax-2).
2.6. Assay of reactive oxygen species (ROS) production and
determination of the NAD(P)H redox state
Generation of mitochondrial ROS was evaluated in isolated mito-
chondria in medium PT-1 using DCFH as a probe as described [20].
DCF formation was monitored using a Jobin Yvon FluoroMax-2
spectro£uorimeter. The oxidation of NAD(P)H in the mitochondria
was measured at excitation and emission wavelengths of 350 and 450
nm as described [21]. All assays were carried out in triplicate.
2.7. Western blotting for cyt c release
Isolated mitochondria in medium PT-1 were incubated in the pres-
ence of recombinant caspase-3 at room temperature. Mitochondrial
supernatant was then assayed using cyt c monoclonal antibody as
described [22].
3. Results
3.1. Recombinant caspase-3 induces cyt c release from
isolated mitochondria
We previously observed that caspase-3 could induce cyt c
release from isolated mitochondria from cultured IM-9 cells, a
multiple myeloma cell line. Using mitochondria isolated from
mouse liver, we con¢rmed that recombinant caspase-3-in-
duced release of cyt c from mitochondria was inhibited by
z-VAD.fmk. Moreover, we found that Bcl-xL and CsA, com-
monly used blockers for PTP, blocked the e¡ects of caspase-3
on cyt c release (Fig. 1), suggesting that caspase-3 could in-
duce PTP opening which may be responsible for cyt c release.
3.2. Recombinant caspase-3 induces the opening of PTP and
loss of mitochondrial membrane potential (v8m)
To directly prove that caspase-3 could induce PTP opening,
we treated the isolated mitochondria with recombinant cas-
pase-3 and measured mitochondrial swelling, indicative of
PTP opening. We found that recombinant caspase-3 induced
PTP opening in a dose-dependent manner. Both CsA and Bcl-
xL inhibited the mitochondrial swelling induced by caspase-3
(Fig. 2). Loss of v8m was a hallmark for mitochondrial ap-
optosis and another indication of opening of PTP. Thus, we
further examined the e¡ect of caspase-3 on v8m. Using
Rh123 to measure v8m, we found that caspase-3 can induce
the loss of v8m in a dose-dependent manner. High doses of
caspase-3 induced almost complete loss of v8m as compared
with CCCP, a commonly used uncoupler for the dissipation of
Fig. 1. Recombinant caspase-3 induces cyt c release from isolated
mitochondria. Isolated mitochondria (1 mg/ml) were treated for 15
min at 25‡C with recombinant caspase-3 (6 U/ml) or in the presence
of Bcl-xL, CsA or z-VAD.fmk in medium PT-1. Lane 1, pellet of
untreated mitochondria. Lane 2, supernatant of untreated mitochon-
dria. Lane 3, supernatant of caspase-3 (6 U/ml)-treated mitochon-
dria. Lanes 4 and 5, supernatant of caspase-3-treated mitochondria
in the presence of Bcl-xL (16 Wg/ml) and CsA (1 WM). Lane 6, 1 WM
z-VAD.fmk was preincubated with caspase-3 for 15 min and then
the mixture was added to the mitochondria.
Table 1
E¡ect of recombinant caspase-3 on mitochondrial respiration
Parameter Control (n = 8) Caspase-3 (n = 8) +z-VAD (n = 8) +Bcl-xL (n = 8) +CsA (n = 8)
State 4 11.12 þ 3.50 15.01 þ 2.94* 11.22 þ 3.613 12.20 þ 2.973 12.15 þ 2.493
State 3 38.17 þ 16.25 38.15 þ 14.55 37.75 þ 16.24 37.22 þ 13.93 37.96 þ 12.67
RCR 3.33 þ 0.48 2.49 þ 0.61* 3.27 þ 0.413 2.81 þ 0.46*3 2.96 þ 0.46*3
Mitochondrial oxygen consumption rates in succinate (4.2 mM)-stimulated state 4 respiration and ADP (200 nM)-stimulated state 3 respiration
were monitored at 25‡C in medium PT-1 as described. Mitochondria were treated without caspase-3 (control) or with caspase-3 (column 2), or
mitochondria were preincubated with z-VAD.fmk (1 WM) (column 3), or in the presence of Bcl-xL (16 Wg/ml, column 4) or CsA (1 WM, column
5) before caspase-3 addition. *P6 0.05 (compared with control group); 3P6 0.05 (compared with caspase-3 group). P values (one-way AN-
OVA): parameters include O2 consumption with ADP (state 3) and without ADP (state 4), RCR (state 3/state 4). Units for state 3 and state 4
O2 consumption are Wmol O2/min/g assuming 258 Wmol O2/l at 25‡C.
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the proton gradient across the inner mitochondrial membrane.
The caspase-3-induced uncoupling e¡ect of v8m was pre-
vented by z-VAD.fmk, CsA or Bcl-xL (Fig. 3).
3.3. Caspase-3 induces an increase in state 4 respiration rate
without impact on state 3 respiration in isolated
mitochondria from mouse liver
As shown in Table 1, incubation of caspase-3 with mito-
chondria for 3 min induced an increase of 35% in state 4
respiration rate in comparison with the untreated samples,
but no e¡ect on state 3 respiration rate. Thus, RCR dropped
25% in comparison with control. When caspase-3 was prein-
cubated with the caspase inhibitor z-VAD.fmk, the stimulat-
ing e¡ect on state 4 respiration was completely blocked and
RCR was largely restored. CsA and Bcl-xL inhibit the cas-
pase-3-induced increase of state 4 respiration rate without
a¡ecting the rates of state 3 respiration.
3.4. Caspase-3 enhances ROS production and NAD(P)H
oxidation in mitochondria
Mitochondria are the major places for the production of
superoxide and hydrogen peroxide in the cell. We and others
have shown that cyt c release from mitochondria could result
in an increase in production of ROS in the cells, which is
associated with the induction of PTP opening. Thus, we ex-
amined the e¡ects of recombinant caspase-3 on ROS produc-
tion in isolated mitochondria. We used DCFH-DA to mea-
sure ROS production in isolated mitochondria [20] and found
that caspase-3 increased the rate of ROS generation in iso-
lated mitochondria in a dose-dependent manner (Fig. 4). The
induction of ROS reached its highest level when caspase-3 was
added at a concentration of 6 U/ml. Bcl-xL, CsA and z-
VAD.fmk inhibited the increase of ROS generation. The lev-
els of ROS were measured in the presence of succinate, so it is
possible that the measured ROS was produced at the site of
complex III in the respiratory chain. Exogenously added
superoxide dismutase has no e¡ect on recombinant caspase-
3-induced ROS increase.
The ratio of the reduced form versus oxidized form of
NAD(P)H is an indicator for the redox potential in the mi-
tochondria. We next examined the e¡ects of recombinant cas-
pase-3 on the oxidation of NAD(P)H and found that caspase-
3 induces NAD(P)H oxidation in mitochondria. Also, z-
VAD.fmk, Bcl-xL and CsA inhibit the oxidation reaction
(Fig. 5).
Fig. 2. Recombinant caspase-3 induces mitochondrial swelling inhibited by Bcl-xL and CsA. Mitochondrial swelling was monitored as described
in Section 2. Trace a, 6 U/ml was added as indicated. Trace b, X (53.3 WM) was preincubated with mitochondria ¢rst and XO (0.024 unit/ml)
was added at 150 s. Trace c, caspase-3 preincubated with z-VAD.fmk then the mixture (caspase-3, 6 U/ml) was added at 150 s. Trace d, mito-
chondria only without additions. Traces e and f, CsA (1 WM) and Bcl-xL (16 Wg/ml) were ¢rst incubated with the mitochondria, then caspase-3
(6 U/ml) was added as indicated.
Fig. 3. Recombinant caspase-3-induced loss of membrane potential
is inhibited by Bcl-xL and CsA. Mitochondria were incubated in the
presence of the caspase-3 (6 U/ml) or caspase-3 pretreated with z-
VAD.fmk. Assays were carried out as described in Section 2. 100%
decrease of mitochondrial membrane potential was de¢ned using
CCCP (10 WM) as an internal control.
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Fig. 4. Recombinant caspase-3 induces an increase of mitochondrial ROS; e¡ects of z-VAD.fmk, Bcl-xL and CsA. Generation of mitochondrial
ROS was evaluated as described in Section 2. Trace a, caspase-3 (6 U/ml) was added (arrow). Trace b, caspase-3 (6 U/ml) and z-VAD.fmk
(1 WM) were preincubated before addition at 300 s. Traces c and d, Bcl-xL (16 Wg/ml) or CsA (1 WM) was preincubated with the mitochondria
before caspase-3 (6 U/ml) was added as indicated. Trace e, control. Inset: Dose-dependent e¡ects of caspase-3 on mitochondrial ROS produc-
tion increase in isolated mitochondria. Increase of ROS generation rate was calculated according to the di¡erence of the slope before and after
caspase-3 was added. The unit is cps/mg protein/ml/s. Column 1, mitochondria only. Column 2, increase of ROS production rate after addition
of caspase-3 (1.5 U/ml). Columns 3^5, addition of caspase-3 reached 3, 4.5 and 6 U/ml, respectively. cps, cycle per second.
Fig. 5. Caspase-3 induces oxidation of NAD(P)H: e¡ects of z-VAD.fmk, CsA and Bcl-xL. The oxidation of NAD(P)H in the mitochondria
was measured as described above. Trace a, caspase-3 (6 U/ml) was added as indicated (arrow). Traces b and c, Bcl-xL (16 Wg/ml) and CsA
(1 WM) was preincubated with mitochondria before caspase-3 (6 U/ml) was added (arrow). Trace d, control, mitochondria only. Trace e, cas-
pase-3 (6 U/ml) was preincubated with z-VAD.fmk (1 WM) and then the mixture was added to the mitochondrial suspension (1 mg/ml) as indi-
cated (arrow).
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4. Discussion
Caspase-3 is a key executioner for the apoptotic phenotype
[9,23]. We and others previously showed that recombinant
caspase-3 could induce cyt c release in a cell-free system
[16]. Here we show that caspase-3 directly induces PTP open-
ing and the associated mitochondrial apoptotic phenotype.
Thus, we demonstrated that caspase-3 can directly induce
the swelling of mitochondria and the collapse of v8m. Our
results indicate that the induction of PTP opening and loss of
v8m by caspase-3 is not mediated by cytosolic factors such as
tBid as reported, although the target of caspase-induced PTP
opening is not known. We and others recently observed that
caspase-3 could cleave Bcl-2 and turn Bcl-2 into a Bax-like
molecule [16,24]. However, the cleavage of Bcl-2 was detected
2 h after treatment of mitochondria with caspase-3 under
identical experimental conditions, while we observed the
opening of PTP and loss of v8m within minutes. Alterna-
tively, caspase-3 could directly target to PTP. Marzo et al.
showed that caspase-3 causes disruption of mitochondrial
membrane potentials and release of AIF from mitochondria
of mouse liver or DiOC6(3) release from PTP complex-recon-
stituted liposomes in a dose-dependent fashion and also in a
Bcl-2- and Bcl-xL-inhibitable manner [25]. The investigation
of the molecular details underlying the action of caspase-3 on
mitochondrial PTP in apoptosis is currently under way.
It is of interest to note that in our experiments recombinant
caspase-3 could increase mitochondrial respiration rate of
state 4 without a¡ecting state 3 respiration. This suggests
that caspase-3 does not act on the activity of the mitochon-
drial respiratory chain per se, but induces mild uncoupling of
mitochondrial respiration. We also present evidence showing
that caspase-3 induces an increase in ROS production and
oxidation of NAD(P)H from mitochondria in a dose-depen-
dent manner. The ratio of NAD(P)H/NAD(P) is an indica-
tor of the status of redox potential in mitochondria [3]. This is
consistent with the results that caspase-3 induces state 4 res-
piration, which consumes NAD(P)H. These e¡ects were also
blocked by z-VAD.fmk, Bcl-xL and CsA, suggesting that the
caspase e¡ects on mitochondrial redox are downstream events
of mitochondrial PTP opening. However, careful analysis in-
dicates that, upon caspase-3 treatment on mitochondria,
NAD(P)H oxidation and increase of ROS happen immedi-
ately after caspase-3 addition and NAD(P)H oxidation
reaches the highest levels about 4 min after caspase-3 treat-
ment (Figs. 4 and 5). Analysis of the PTP opening reveals that
mitochondrial swelling reaches its highest levels at 7 min (Fig.
2). To reconcile these data, we argue that there may be a self-
amplifying process of caspase activation, NAD(P)H consump-
tion and PTP opening. It is possible that an increase in ROS
generation and increase of state 4 respiration induced by cas-
pase-3 could a¡ect the redox potential in the mitochondria,
which then leads to the oxidation of mitochondrial proteins
and PTP opening. Indeed, ROS produced by the X/XO sys-
tem also caused mitochondria swelling with the same kinetics
as with caspase-3 (Fig. 2). Redox potential and thiol-disul¢de
redox state of the ATP/ADP translocator in the inner mito-
chondrial membrane seems to play a role in controlling PTP
opening [26,27]. On the other hand, PTP opening could result
in the loss of NAD(P)H from mitochondria.
In summary, we observed that recombinant caspase-3 could
directly induce PTP opening, which is causally related to the
loss of mitochondrial membrane potential and cyt c release
from mitochondria. Furthermore, our data suggested that cas-
pase-3 impacts on the mitochondrial respiration and redox
status. These data are consistent with our recent report sug-
gesting that there is a feedback control of cyt c release and
mitochondrial dysfunction mediated by caspases. Further
work is needed to pinpoint targets of caspase-3 on mitochon-
dria.
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